Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6852092rdf:typepubmed:Citationlld:pubmed
pubmed-article:6852092lifeskim:mentionsumls-concept:C0032594lld:lifeskim
pubmed-article:6852092lifeskim:mentionsumls-concept:C0003241lld:lifeskim
pubmed-article:6852092lifeskim:mentionsumls-concept:C0020852lld:lifeskim
pubmed-article:6852092lifeskim:mentionsumls-concept:C0445604lld:lifeskim
pubmed-article:6852092lifeskim:mentionsumls-concept:C0037775lld:lifeskim
pubmed-article:6852092lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:6852092pubmed:issue5lld:pubmed
pubmed-article:6852092pubmed:dateCreated1983-7-29lld:pubmed
pubmed-article:6852092pubmed:abstractTextMice were immunized with hapten [NIP, (4-hydroxy-5-iodo-3-nitrophenyl)acetyl or TNP (2,4,6-trinitrophenyl)] conjugates of Ficoll or pneumococcal polysaccharide type 14 (S14), and they were bled on days 10 or 14. Anti-hapten and anti-polysaccharide antibodies were determined from the sera or from fractions (IgM + IgA). IgG1, IgG2a, IgG3 or IgG2b separated by a gradual acid elution from protein A. Approximately one-half of both anti-hapten and anti-polysaccharide antibodies was found in the IgM + IgA fraction. The subclass distribution of the IgG antibodies was dependent on the antigenic determinants. Polysaccharide antibodies were mostly in the IgG3 fraction (36-62%) and in the IgG1 fraction (18-36%). Hapten IgG antibodies were mostly in the IgG1 fraction (38-74%): each of the other three subclasses contributed the average of 13%. These results provide the first evidence that antibodies to different determinants of one antigen have grossly different isotype distributions.lld:pubmed
pubmed-article:6852092pubmed:languageenglld:pubmed
pubmed-article:6852092pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6852092pubmed:citationSubsetIMlld:pubmed
pubmed-article:6852092pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6852092pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6852092pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6852092pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6852092pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6852092pubmed:statusMEDLINElld:pubmed
pubmed-article:6852092pubmed:monthMaylld:pubmed
pubmed-article:6852092pubmed:issn0014-2980lld:pubmed
pubmed-article:6852092pubmed:authorpubmed-author:MäkeläOOlld:pubmed
pubmed-article:6852092pubmed:authorpubmed-author:PéterfyFFlld:pubmed
pubmed-article:6852092pubmed:authorpubmed-author:SeppäläI JIJlld:pubmed
pubmed-article:6852092pubmed:authorpubmed-author:SarvasH OHOlld:pubmed
pubmed-article:6852092pubmed:authorpubmed-author:AaltonenL MLMlld:pubmed
pubmed-article:6852092pubmed:issnTypePrintlld:pubmed
pubmed-article:6852092pubmed:volume13lld:pubmed
pubmed-article:6852092pubmed:ownerNLMlld:pubmed
pubmed-article:6852092pubmed:authorsCompleteYlld:pubmed
pubmed-article:6852092pubmed:pagination409-14lld:pubmed
pubmed-article:6852092pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:6852092pubmed:meshHeadingpubmed-meshheading:6852092-...lld:pubmed
pubmed-article:6852092pubmed:meshHeadingpubmed-meshheading:6852092-...lld:pubmed
pubmed-article:6852092pubmed:meshHeadingpubmed-meshheading:6852092-...lld:pubmed
pubmed-article:6852092pubmed:meshHeadingpubmed-meshheading:6852092-...lld:pubmed
pubmed-article:6852092pubmed:meshHeadingpubmed-meshheading:6852092-...lld:pubmed
pubmed-article:6852092pubmed:meshHeadingpubmed-meshheading:6852092-...lld:pubmed
pubmed-article:6852092pubmed:meshHeadingpubmed-meshheading:6852092-...lld:pubmed
pubmed-article:6852092pubmed:meshHeadingpubmed-meshheading:6852092-...lld:pubmed
pubmed-article:6852092pubmed:meshHeadingpubmed-meshheading:6852092-...lld:pubmed
pubmed-article:6852092pubmed:meshHeadingpubmed-meshheading:6852092-...lld:pubmed
pubmed-article:6852092pubmed:year1983lld:pubmed
pubmed-article:6852092pubmed:articleTitleIgG subclass distributions in anti-hapten and anti-polysaccharide antibodies induced by haptenated polysaccharides.lld:pubmed
pubmed-article:6852092pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6852092pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:6852092pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6852092lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6852092lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6852092lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6852092lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6852092lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6852092lld:pubmed